SERGIO SALES: Open Payments
NPI 1427430081 · PAOLI, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 18 payments from 6 companies in 2025. Trend: 2023 $359 · 2024 $184 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $153 |
| Lilly USA, LLC | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Indivior Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Novo Nordisk Inc | 1 | $14 |
Products named: UBRELVY, QULIPTA, VRAYLAR, MOUNJARO, SUBLOCADE, CAPLYTA, BREZTRI, Ozempic.
Industry payments across IN — which companies pay providers there.
